Biostem Technologies IncOTC Pink - Current Information:BSEM
- LAST PRICE9.5500
- TODAY'S CHANGE (%)0.1500 (1.5957%)
- Bid / Lots9.4100/ 5
- Ask / Lots9.6000/ 3
- Open / Previous Close9.4200 / 9.4000
- Day Range
- 52 Week Range
- Volume548
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BSEM |
|---|---|---|
| 09:50 ET | 199 | 9.42 |
| 10:06 ET | 150 | 9.55 |
Yesterday
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase, from 8:00AM ET on Thursday Apr 25, 2024 by Dow Jones
8:00AM ET on Thursday Apr 25, 2024 by Dow Jones
Apr 24, 2024
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange, from 8:01AM ET on Wednesday Apr 24, 2024 by Dow Jones
8:01AM ET on Wednesday Apr 24, 2024 by Dow Jones
Apr 2, 2024
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference, from 8:00AM ET on Tuesday Apr 02, 2024 by Dow Jones
8:00AM ET on Tuesday Apr 02, 2024 by Dow Jones
Apr 1, 2024
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase, from 4:05PM ET on Monday Apr 01, 2024 by Dow Jones
4:05PM ET on Monday Apr 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biostem Technologies Inc | 152.4M | 0.0x | --- |
ASP Isotopes Inc | 165.4M | -7.0x | --- |
Hongchang International Co Ltd | 115.5M | -258.8x | --- |
scPharmaceuticals Inc | 156.8M | -3.1x | --- |
Telomir Pharmaceuticals Inc | 201.3M | -14.0x | --- |
Cellectar Biosciences Inc | 97.4M | -1.0x | --- |
Company Information
BioStem Technologies, Inc. is focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts and regenerative therapies. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. Its products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AmnioWrap2. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. AmnioWrap is a placental-based allografts comprised of unseparated amnion and chorion membranes, including the intact intermediate layer.
Contact Information
- Headquarters
- 2836 Center Port CirPOMPANO BEACH, FL, United States 33064-2136
- Phone
- 954-380-8342
- Fax
- ---
Executives
- Chairman of the Board
- Thomas Dugan
- President, Chief Executive Officer, Director
- Marc Barhonovich
- Chief Financial Officer, Secretary, Treasurer, Director
- Leon Willis
- Chief Commercial Officer
- Shawn Mccarrey
- Chief Medical Officer
- Dave Woynarowski
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $152.4M |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | 16.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.71 |
EPS | --- |
Book Value | $-0.58 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
